======= SMYD2 =======
== Gene Information ==
* **Official Symbol**: SMYD2
* **Official Name**: SET and MYND domain containing 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56950|56950]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NRG4|Q9NRG4]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SMYD2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SMYD2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/610663|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Protein-lysine N-methyltransferase that methylates both histones and non-histone proteins, including p53/TP53 and RB1. Specifically methylates histone H3 'Lys-4' (H3K4me) and dimethylates histone H3 'Lys-36' (H3K36me2). Shows even higher methyltransferase activity on p53/TP53. Monomethylates 'Lys-370' of p53/TP53, leading to decreased DNA-binding activity and subsequent transcriptional regulation activity of p53/TP53. Monomethylates RB1 at 'Lys-860'. {ECO:0000269|PubMed:17108971, ECO:0000269|PubMed:17805299, ECO:0000269|PubMed:18065756, ECO:0000269|PubMed:20870719, ECO:0000269|PubMed:21782458, ECO:0000269|PubMed:21880715}.
|SET|
|zf-MYND|
|lysine N-methyltransferase activity|
|histone H3-K36 methylation|
|histone methyltransferase activity (H3-K36 specific)|
|peptidyl-lysine monomethylation|
|peptidyl-lysine dimethylation|
|protein-lysine N-methyltransferase activity|
|RNA polymerase II complex binding|
|regulation of DNA damage response, signal transduction by p53 class mediator|
|p53 binding|
|histone lysine methylation|
|peptidyl-lysine methylation|
|histone methylation|
|protein methylation|
|protein alkylation|
|regulation of signal transduction by p53 class mediator|
|regulation of response to DNA damage stimulus|
|macromolecule methylation|
|methylation|
|peptidyl-lysine modification|
|histone modification|
|covalent chromatin modification|
|heart development|
|negative regulation of cell population proliferation|
|chromatin organization|
|regulation of cellular response to stress|
|negative regulation of transcription by RNA polymerase II|
|circulatory system development|
|peptidyl-amino acid modification|
|chromosome organization|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|regulation of response to stress|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|regulation of cell population proliferation|
|negative regulation of gene expression|
|regulation of intracellular signal transduction|
\\
=== CRISPR Data ===
No hits were found.
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 18089
* **Expression level (log2 read counts)**: 5.71
{{:chemogenomics:nalm6 dist.png?nolink |}}